CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

NCT00211939 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Calcinosis
Arteriosclerosis
Hyperparathyroidism, Secondary

Interventions

DRUG: calcium acetate
DRUG: sevelamer
DRUG: atorvastatin

Sponsor

Nabi Biopharmaceuticals